Skip to main content
. 2018 Mar 15;11:42. doi: 10.1186/s13045-018-0585-5

Fig. 3.

Fig. 3

Changes in age-matched hematopoietic cellularity at different time points following ruxolitinib therapy. Values less than 1.0 indicate decreased cellularity, 1.0 reflects normal marrow cellularity, while values greater than 1.0 indicate increased cellularity